Gane, E. J., Stedman, C. A., Hyland, R. H., Ding, X., Svarovskaia, E., Symonds, W. T. et al. (2013). Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C. New England Journal of Medicine, 368, 34-44.
https://doi.org/10.1056/NEJMoa1208953

has been cited by the following article:

• TITLE: Therapeutic and Diagnostic Approaches for SARS-CoV-2

  AUTHORS: Fereshteh Moshfegh, Andia Ezzati, Azita Ezzati, Mehran Bahraini, Ebrahim Boluki, Alieh Fazeli

  KEYWORDS: COVID-19 Diagnostic Testing, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Drug Treatment, High-Throughput Nucleotide Sequencing

  JOURNAL NAME: Voice of the Publisher, Vol.7 No.2, April 21, 2021

  ABSTRACT: Epidemic control of severe acute respiratory syndrome Coronavirus 2 (SARS- CoV-2) infections is becoming a global health crisis and diagnostic testing to identify infected persons is indispensable. Although various aspects of the virus are still unknown to the public, early diagnosis, lockdown, and supportive care are required to treat patients. This paper reviews the literature on available information about the diagnostic method with greater emphasis on next-generation sequencing (NGS) technology and a novel therapeutic approach to COVID-19.